Entera Bio ENTX
NASDAQ ENTX
$2.89 -0.02 (-0.69%)
At close: Oct 1, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Liabilities and Shareholders Equity (2017 - 2026)

Updated

Entera Bio (ENTX) reported Liabilities and Shareholders Equity of $19.48 million for Q2 2026, down 1.0% from $19.67 million a year earlier but up 48.4% from the prior quarter.

Analysis

Entera Bio (ENTX) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Entera Bio posted Liabilities and Shareholders Equity of $15.99 million, up 70.3% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of 10.5% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $9.39 million in FY2024 (-20.2%), $11.77 million in FY2023 (-10.4%), $13.13 million in FY2022 (-49.5%) and $25.99 million in FY2021 (+167.3%).
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $7.74 million in Q3 2024 and a high of $25.99 million in Q4 2021.
  • Year over year, Liabilities and Shareholders Equity gained in four of the last eight quarters, with growth averaging 41.5%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 167.3%); the low point was Q4 2022 (a decline of 49.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $13.13 million (Q1 2026), $15.99 million (Q4 2025) and $17.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Entera Bio 143.43 Mn 112.31 Mn - 19.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.48 Mn
Mar 31, 2026 13.13 Mn
Dec 31, 2025 15.99 Mn
Sep 30, 2025 17.41 Mn
Jun 30, 2025 19.67 Mn
Mar 31, 2025 21.60 Mn
Dec 31, 2024 9.39 Mn
Sep 30, 2024 7.74 Mn
Jun 30, 2024 10.04 Mn
Mar 31, 2024 10.24 Mn
Dec 31, 2023 11.77 Mn
Sep 30, 2023 8.57 Mn
Jun 30, 2023 10.45 Mn
Mar 31, 2023 11.61 Mn
Dec 31, 2022 13.13 Mn
Sep 30, 2022 15.54 Mn
Jun 30, 2022 19.09 Mn
Mar 31, 2022 22.31 Mn
Dec 31, 2021 25.99 Mn
Jun 30, 2021 28.94 Mn
API Access

Entera Bio Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ENTX&period=max&api_key=YOUR_API_KEY